Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 2/20 | 0.42 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
| ▸ | FDPS | P14324 | 3/20 | 0.34 |
| ▸ | SMPD1 | P17405 | 3/20 | 0.34 |
| ▸ | GPR84 | Q9NQS5 | 2/20 | 0.33 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4261190 | 0.97 | DNM1 (0.46) | DNM1OPRM1LMNACA2TSHR | |
| SCHEMBL2347365 | 0.97 | DNM1 (0.46) | DNM1OPRM1LMNACA2TSHR | |
| SCHEMBL18007368 | 0.97 | OPRM1 (0.42) | DNM1OPRM1LMNATSHRTHRB | |
| SCHEMBL4263651 | 0.95 | LMNA (0.42) | DNM1OPRM1LMNATSHRTHRB | |
| SCHEMBL1582541 | 0.95 | DNM1 (0.39) | DNM1OPRM1LMNACA2TSHR | |
| SCHEMBL4274138 | 0.90 | LMNA (0.39) | DNM1OPRM1LMNATSHRTHRB | |
| SCHEMBL3899908 | 0.90 | DNM1 (0.36) | DNM1LMNACA2TSHRFDPS | |
| SCHEMBL7799148 | 0.87 | OPRM1 (0.39) | DNM1OPRM1LMNATSHRTHRB | |
| SCHEMBL4263383 | 0.84 | — | — | |
| SCHEMBL21232740 | 0.81 | LMNA (0.52) | LMNATSHRSMPD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1375485-B1 | METHOD FOR PREPARING 7-QUINOLINYL-3,5-DIHYDROXYHEPT-6-ENOATE | NISSAN CHEMICAL IND LTD (JP) | 2011-04-20 | — | — | EP | disclosed |
| US-7038056-B2 | Method for preparing a 7-quinolinyl-3,5-dihydroxyhept-6-enoate | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2006-05-02 | — | — | US | disclosed |
| US-20050014947-A1 | Method for preparing a 7-quinolinyl-3, 5-dihydroxyhept-6-enoate | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2005-01-20 | — | — | US | disclosed |
| EP-1375485-A1 | METHOD FOR PREPARING 7-QUINOLINYL-3,5-DIHYDROXYHEPT-6-ENOATE | Nissan Chemical Industries, Ltd. (JP) | 2004-01-02 | — | — | EP | disclosed |
| EP-0519496-B1 | Thermosetting copolymers, silicon carbide-based fiber and processes for producing same | TONEN CORP (JP) | 1996-05-22 | — | — | EP | disclosed |
| EP-0404503-B1 | Boron-containing, silicon nitride-based ceramic shaped body production process | TONEN CORP (JP) | 1996-03-06 | — | — | EP | disclosed |
| EP-0389084-B1 | Process for producing a polyborosilazane | TONEN CORP (JP) | 1995-09-20 | — | — | EP | disclosed |
| EP-0415704-B1 | Catalysts for polymerization of olefins | CHISSO CORP (JP) | 1995-05-10 | — | — | EP | disclosed |
| US-5292830-A | Silane, silazane, boron block crosslinked copolymers | TONEN CORPORATION (JP) | 1994-03-08 | — | — | US | disclosed |
| EP-0519496-A1 | Thermosetting copolymers, silicon carbide-based fiber and processes for producing same | Tonen Corporation (JP) | 1992-12-23 | — | — | EP | disclosed |
| US-5128286-A | BORON-CONTAINING, SILICON NITRIDE-BASED CERAMIC SHAPED BODY | TONEN CORPORATION (JP) | 1992-07-07 | — | — | US | disclosed |
| US-5122490-A | Composed of organomagesium compounds, titanium and vanadium halides, alcohols, halogenated silanes, siloxanes, borates, electron donors and cyclic ether | CHISSO CORPORATION (JP) | 1992-06-16 | — | — | US | disclosed |
| US-5084429-A | Coordination catalysts for olefin polymerization from magnesium, titanium, vanadium and silicon compounds | CHISSO CORPORATION (JP) | 1992-01-28 | — | — | US | disclosed |
| US-5030744-A | Polyborosilazane and process for producing same | TONEN CORPORATION (JP) | 1991-07-09 | — | — | US | disclosed |
| EP-0415704-A2 | Catalysts for polymerization of olefins | CHISSO CORPORATION (JP) | 1991-03-06 | — | — | EP | disclosed |
| EP-0404503-A1 | Boron-containing, silicon nitride-based ceramic shaped body production process | Tonen Corporation (JP) | 1990-12-27 | — | — | EP | disclosed |
| EP-0389084-A2 | Process for producing a polyborosilazane | Tonen Corporation (JP) | 1990-09-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050014947-A1 | Method for preparing a 7-quinolinyl-3, 5-dihydroxyhept-6-enoate | QDPR, DHCR7, GHRHR | DNM1 3268/4885OPRM1 1768/4885LMNA 4511/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.